David M Nathan, William H Herman. Show Affiliations »
Abstract
Entities: Disease
Mesh: See more » Cost-Benefit AnalysisDiabetes Mellitus, Type 2/complicationsDiabetes Mellitus, Type 2/diagnosisDiabetic Angiopathies/complicationsHumansHypertension/complicationsMass Screening/economics
Year: 2004 PMID: 15126261 DOI: 10.7326/0003-4819-140-9-200405040-00017
Source DB: PubMed Journal: Ann Intern Med ISSN: 0003-4819 Impact factor: 25.391